Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment

Condition:   Small-cell Lung Cancer Intervention:   Drug: Serplulimab Sponsors:   Guangdong Association of Clinical Trials;   Guangdong Provincial People's Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials